By J.C. Rivera, Pedcor Investments LLC
Oregon became the latest state to address “Right to Try Laws” by passing a bill that contradicts an FDA restriction on experimental drug use in terminal patients, known as the “Oregon Right to Try Act”. Currently, the FDA allows patients with life-threatening diseases to access experimental drugs with FDA consent. The Oregon Act eliminates the requirement of FDA approval and allows the patient to access the drug directly from the manufacturer. The Oregon Right to Try Act also carves out protection for health care providers. A copy of the Oregon bill can be found here.
This post was written by J.C. Rivera of Pedcor Investments LLC. If you would like to submit content or write an article for the Health Care and Life Sciences Section page, please email Rachel Beachy at email@example.com.